GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
40.83
-0.65 (-1.57%)
At close: Sep 12, 2025, 4:00 PM EDT
40.85
+0.02 (0.05%)
After-hours: Sep 12, 2025, 7:53 PM EDT
GSK Revenue
GSK had revenue of 7.99B GBP in the quarter ending June 30, 2025, with 1.29% growth. This brings the company's revenue in the last twelve months to 31.63B, up 0.59% year-over-year. In the year 2024, GSK had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.63B GBP
Revenue Growth
+0.59%
P/S Ratio
1.89
Revenue / Employee
460,898 GBP
Employees
68,629
Market Cap
82.03B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
GSK News
- 3 days ago - US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says - Reuters
- 10 days ago - Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday? - Benzinga
- 23 days ago - Dynavax's shingles vaccine shows similar immune response to GSK's shot in study - Reuters
- 4 weeks ago - GSK's antibiotic drug gepotidacin gets priority review by FDA - Reuters
- 5 weeks ago - GSK to Receive $370 Million in U.S. Patent Litigation Settlement - WSJ
- 6 weeks ago - Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges - WSJ
- 6 weeks ago - Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says - Forbes
- 6 weeks ago - Trump pressures 17 pharma CEOs to cut US drug prices - Reuters